Free Newsletter
Humana to study adverse reactions
In an unprecedented initiative, the University of Miami and Humana are joining forces to study drug safety and adverse reactions. Researchers will track Humana's database of 11 million members, looking for dangerous side effects that become apparent only after a drug has been used for some time. Dubbed the Pharmacovigilance Initiative, the program is an attempt to reach beyond voluntary reporting of adverse drug reactions. Results will be reported publicly via press releases and a special website beginning in 2008.
- check out the release on the program
- here's the report on the initiative from the South Florida Business Journal
Related Articles:
Humana, University of Miami take on 'pre-sick.' Report
Pharmacovigilance grows in importance. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment